CORDIS Project
Funding breakdown and partner intelligence are Premium
Sign in and upgrade to Premium for EU contribution totals, consortium analytics, OpenAlex research context, and AI summaries. · 0 consortium intelligence fields visible of 1
Start free • Cancel anytime • 14-day refund guarantee
This project focuses on identifying and validating therapeutic targets to prevent and treat fibrosis in patients with inflammatory bowel diseases. It aims to develop non-invasive imaging techniques for diagnosing fibrosis and to test novel immunotherapies in preclinical models, ultimately leading to a first-in-human cl…
Fibrostenosis is the driving reason for the persistent need in bowel resections in inflammatory bowel diseases (IBD).
Current IBD therapies are limited to solely targeting inflammation.
While these therapies in some, but not all, cases lead to symptomatic disease remission, recurrent flares interspaced with periods of remission will still result in cumulative gut wall remodeling and fibrosis.
Indeed, despite these therapeutic strategies to control inflammation, fibrostenosis incidence and bowel…
KATHOLIEKE UNIVERSITEIT LEUVEN
Partner organizations (coordinator is shown above), with normalized type and CORDIS activity type. Guests see up to 4 partners.
Spain, Barcelona
Type: Research institute
Activity type: Research Organisations
SME: No
Germany, Erlangen
Type: University / higher education
Activity type: Higher or Secondary Education Establishments
SME: No
Spain, Barcelona
Type: SME
Activity type: Private for-profit entities (excluding Higher or Secondary Education Establishments)
SME: Yes
Similar projects, consortium collaboration history, frequent partners, and OpenAlex research context.
Guests see up to 5 EuroSciVoc fields.
Guests see up to 5 topics.
Guests see up to 5 sectors.
Guests see up to 5 keywords.
